This inventor holds 2 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Memorial Sloan Kettering Cancer Center, Cornell University, University of Missouri. Active years: 2019-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 621 
1 out of 2,953 
1 out of 898 
Years Active: 2019-2023
Title: Innovations of Wolfgang Weber
Introduction
Wolfgang Weber is a notable inventor based in Larchmont, NY (US). He has made significant contributions to the field of nanotechnology and cancer therapeutics, holding 2 patents that showcase his innovative work.
Latest Patents
One of his latest patents is titled "Inhibitor-functionalized ultrasmall nanoparticles and methods thereof." This patent describes novel conjugates that contain an inhibitor, such as a PSMA inhibitor or a gastrin-releasing peptide receptor inhibitor, covalently attached to a macromolecule like a nanoparticle or polymer. These conjugates exhibit distinct properties compared to the free, unbound inhibitor/chelator construct. Another significant patent is "Radiohalide-labeled targeted diagnostics and therapeutics." This patent discloses chemical entities that are radiative emitters, useful as therapeutic agents for treating cancers, particularly those in which PARP1 is overexpressed.
Career Highlights
Wolfgang Weber has worked with prestigious institutions, including Memorial Sloan Kettering Cancer Center and Cornell University. His work in these organizations has contributed to advancements in cancer research and treatment methodologies.
Collaborations
Some of his notable coworkers include Michelle S. Bradbury and Thomas P. Quinn, who have collaborated with him on various projects in the field of cancer therapeutics.
Conclusion
Wolfgang Weber's innovative patents and career achievements highlight his significant contributions to the fields of nanotechnology and cancer treatment. His work continues to influence advancements in medical research and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile